| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/28/2013 | CN103263520A Traditional Chinese medicine for treating prostatitis |
| 08/28/2013 | CN103263511A Traditional Chinese medicinal composition for treating congealing cold bartholinitis |
| 08/28/2013 | CN103263460A New method for preparing compound stranguria-treating and calculus-removing tablets |
| 08/28/2013 | CN103263425A Application of fosfomycin trometamol to preparation of drug for treating chronic bacterial prostatitis |
| 08/28/2013 | CN103263419A New application of pharmaceutical composition of metformin and 5-methyltetrahydrofolate |
| 08/28/2013 | CN103142703B Processing technology of anti-mildew of frutus forsythiae |
| 08/28/2013 | CN102872153B Application of Houttuynoid E in medicament for preventing and treating renal insufficiency |
| 08/28/2013 | CN102872140B Application of Houttuynoid C in drug for treating acute renal failure |
| 08/28/2013 | CN102872070B Application of Houttuynoid C to preparing drugs for treating prostate cancer |
| 08/28/2013 | CN102872041B Application of Gypensapogenin A in medicaments for preventing and treating renal insufficiency |
| 08/28/2013 | CN102846595B Application of flavonoid compound WX-03 in relaxation of vascular smooth muscles |
| 08/28/2013 | CN102727624B New application of enteritis peaching composition on treatment of chronic prostatitis |
| 08/28/2013 | CN102614393B Preparation method for traditional Chinese drug for treatment of dampness-heat and stagnation type prostatitis |
| 08/28/2013 | CN102600392B Traditional Chinese medicine enema for treating chronic renal failure |
| 08/28/2013 | CN102321079B (-) doxazosin mesylate crystal VI as well as preparation method and application thereof |
| 08/28/2013 | CN102321078B Doxazosin mesylate III form crystal, and preparation method and usage thereof |
| 08/28/2013 | CN102266420B Method for preparing heartleaf houttuynia herb injection |
| 08/28/2013 | CN102260266B Pyrazolo[3,4-d]pyrimidone compounds and application thereof in preparation of phosphodiesterase IX inhibitor |
| 08/28/2013 | CN102258557B Medicament for treating prostatic hyperplasia |
| 08/28/2013 | CN101986781B Crystalline I-(3-fluorophenyl)-5-methyl-2-(1H)pyridone, the preparation methods, compositions and applications thereof |
| 08/28/2013 | CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/27/2013 | US8518995 Methods and compositions for the treatment of irritable bowel syndrome |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518916 Heterocyclic derivatives as M-GLU5 antagonists |
| 08/27/2013 | US8518447 Method for treating or preventing renal or liver disease |
| 08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/22/2013 | WO2013123218A1 Selective estrogen receptor modulators with short half-lives and uses thereof |
| 08/22/2013 | WO2013123165A1 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid [1,3]dioxol-4-ylmethyl ester |
| 08/22/2013 | WO2013120771A1 Imidazolylketone derivatives asd aldosterone synthase inhibitors |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/22/2013 | US20130217129 Conditioned cell culture medium compositions and methods of use |
| 08/22/2013 | US20130217069 Conditioned cell culture medium compositions and methods of use |
| 08/21/2013 | EP2628733A1 Acylbenzene derivative |
| 08/21/2013 | EP2628483A1 Medical adsorbent and method for producing same |
| 08/21/2013 | EP2627331A1 Methods for treating hyperuricemia and related diseases |
| 08/21/2013 | EP2627313A2 Phosphate binder formulation for simple ingestion |
| 08/21/2013 | CN203138934U Magnetic health-care mattress for treating osphyalgia, leg pain and bedsore |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
| 08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
| 08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 08/21/2013 | CN103260630A Medical adsorbent and method for producing same |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254155A Tetrahydropyrrole derivative and preparation method thereof |
| 08/21/2013 | CN103254088A Tapentadol hydrochloride crystal form D as well as preparation method and application thereof |
| 08/21/2013 | CN103251917A Traditional Chinese medicine suppository for treating gynecological diseases |
| 08/21/2013 | CN103251868A Kidney-clearing particles for treating chronic renal failure and preparation method thereof |
| 08/21/2013 | CN103251788A Vitamin water agent |
| 08/21/2013 | CN103251752A Shenshitong granules and preparation method thereof |
| 08/21/2013 | CN103251728A Red ginseng-prepared rehmannia root particles for treating chronic nephritis and preparation method thereof |
| 08/21/2013 | CN103251710A Medicine composite for preventing or treating diabetic nephropathy and application of medicine composite |
| 08/21/2013 | CN103251685A Rumex nepalensis spreng extract and application of the same in drug preparation |
| 08/21/2013 | CN103251684A Medicine composition for treating kidney stone and preparation method of drug composition |
| 08/21/2013 | CN103251637A Application of Polyflavanostilbene A in preparing medicine for treating acute renal failure |
| 08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
| 08/21/2013 | CN103251630A Medical and health-care medicine of natural brassinolide |
| 08/21/2013 | CN103251606A Application of Myriberine A in preparing medicine for treating renal insufficiency |
| 08/21/2013 | CN103251603A Application of Myriberine A in preparation of medicines for treating and preventing renal fibrosis |
| 08/21/2013 | CN103251585A Effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A |
| 08/21/2013 | CN103006999B Pill for preventing, curing and nursing renal calculi |
| 08/21/2013 | CN102743567B Traditional Chinese medicine for treating chronic prostatitis |
| 08/21/2013 | CN102397314B Health-care product for preventing and treating renal disease of newborn Tibetan mastiff in low-altitude region |
| 08/21/2013 | CN102380082B Traditional Chinese medicine preparation for treating kidney stones |
| 08/21/2013 | CN102311383B Phenazopyridine hydrochloride crystal compound and pharmaceutical composition tablet thereof |
| 08/21/2013 | CN102293873B Preparation method of Bazheng mixture |
| 08/21/2013 | CN102258649B Chinese medicinal composition for treating infant frequent micturition |
| 08/21/2013 | CN102171329B Lactic acid bacterium having high oxalic acid decomposition ability |
| 08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
| 08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
| 08/20/2013 | US8513279 Quinuclidine derivatives and medicinal compositions containing the same |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513189 Albumin fusion proteins |
| 08/20/2013 | US8513188 Formulations comprising cyclic compounds |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | CA2587924C Oral compositions for absorption of phosphorus compounds |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/15/2013 | WO2013119910A1 Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder |
| 08/15/2013 | US20130211490 Everolimus Eluting Bioabsorbable Renal Artery Stent For Renal Cancer And Inflammatory Disorders |
| 08/15/2013 | US20130210725 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130210135 Recombinant vsv for the treatment of tumor cells |
| 08/15/2013 | US20130210076 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130209456 Subtypes of humanized antibody against interleukin-6 receptor |
| 08/15/2013 | US20130209398 Conditioned cell culture medium compositions and methods of use |
| 08/14/2013 | EP2626351A1 Agent for inhibiting expression of lipid metabolism related mrna |
| 08/14/2013 | EP2626350A1 Cyclopropane compound |
| 08/14/2013 | EP2626348A1 Heterocyclic amides as rock inhibitors |
| 08/14/2013 | EP2624828A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 08/14/2013 | CN103249727A New biaryl amide derivatives |
| 08/14/2013 | CN103249726A Acylbenzene derivative |
| 08/14/2013 | CN103249417A Methods for treating hyperuricemia and related diseases |
| 08/14/2013 | CN103242341A Thieno 2,4-substituted pyrimidine compound, and pharmaceutical composition and application thereof |
| 08/14/2013 | CN103242230A Quinolinone derivative and preparation method thereof |
| 08/14/2013 | CN103239706A Earthworm protein for reducing blood glucose, improving microcirculation and eliminating diabetic complication and application thereof |
| 08/14/2013 | CN103239695A Preparation method of traditional Chinese medicine for treating alcohol-related acute glomerulonephritis |
| 08/14/2013 | CN103239669A Traditional Chinese medicinal preparation for treating diabetic nephropathy |
| 08/14/2013 | CN103239652A Pharmaceutical composition for treatment of chronic kidney disease and preparation method and application thereof |
| 08/14/2013 | CN103239626A Medicament formula for healthcare and treatment of middle-aged and elderly people |